TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Rental Agreement for a high sensitivity Tandem Mass Spectrometer - High Performance Liquid Chromatography system for analysis of hormones biological fluids.

No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST: "Rental Agreement for a high sensitivity Tandem Mass Spectrometer - High Performance Liquid Chromatography system for analysis of hormones biological fluids.". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityCAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUSTScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationHigh Concentration
VYAIRE UK 236 LIMITEDTop vendor: 69.4% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 700 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
VYAIRE UK 236 LIMITED1 win£2,014,193
P2G Contract Support LLP1 win£100,000
SOFTCAT PLC1 win£90,405
Mills & Reeve1 win£81,264
STRYKER UK LIMITED1 win£76,900
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published22 Jul 2026, 06:47 BST
Last source update22 Jul 2026, 06:47 BST
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-06d056
What is being bought
The CUH Blood Sciences Biochemical Genetics Unit is looking to replace a high sensitivity Triple Quadrupole Tandem Mass Spectrometer (TMS) coupled to an ultra-high pressure liquid chromatography (HPLC) system. This system runs 10 methods including newborn blood spot analysis that were developed either in-house or in conjunction with suppliers. The Blood Sciences labs currently have four Sciex triple quadrupole tandem mass spectrometers (TMS) linked to Shimadzu or Sciex (Exion) liquid chromatography (HPLC) systems. This includes the system that we are replacing. The combined laboratories currently process around 120,000 samples a year through the four LC-Tandem Mass Spectrometer systems. Results generated from the systems are from technically/clinically validated methods and are used for diagnosis of endocrine and metabolic disorders, as well as for neonatal screening tests. The replacement system must be capable of quantitation of a range of metabolites in human serum, urine and blood spot and therefore must be capable of using Chemoview to quantitate the newborn screening blood spot assays. Some of the analytes are at nmol/L concentrations in human serum e.g. urine matanepherine, so a high sensitivity system is essential. The TMS - HPLC system must have the following critical elements: TMS - The TMS must have multiple modes of operation including multiple reaction monitoring and scan modes. Scan modes must include precursor ion scan, product ion scan, neutral loss scan. - The TMS must be capable of Atmospheric Pressure Chemical Ionisation (APCI) and electrospray (ESI) ionisation modes with proven use of APCI for clinical hormone analyses. - The TMS must be capable of positive and negative modes. - The TMS must be capable of polarity switching within a sample acquisition run with a minimum settling time of 5msec between polarities. - The TMS must accept a fluid flow rate from 5µL/min to 3000µL/min, without flow splitting. - To allow for future development needs the TMS must have an option to be upgraded to a linear ion trap system that will provide additional scan modes such as MRM3, Enhanced Product Ion Scan. - The TMS must have an integral infusion pump under full control of the system software to allow infusion rates up to 30µL/min to allow compound tuning and for ion suppression testing. - The TMS control software must be compatible with multi-vendor HPLC systems e.g. Shimadzu, Agilent, Waters. - The system must be capable of the self-generation of all gases required for routine use (i.e. no requirement for a gas cylinder in the lab). - A suitable roughing pump must be supplied. This must be an oil-free pump. - Results must be able to be exported in .txt format to allow uploading to our current hospital information system. - Current methods in use in the Biochemical Genetics Unit must be directly transferrable without the need for re-development. HPLC - The HPLC system must have the ability of a dual binary pump arrangement allowing pressures up to 10,000PSI. This setup is to allow online solid phase extraction using 2-position valves. - There must be a minimum of 4 solvent lines per pump with inline degassers. If binary pumps are proposed, there must be 4 solvent lines for each side of the binary pump. The LC must have the ability to switch to different solvent input lines, analytical columns without operator intervention to allow running of multiple assays to be processed consecutively. - The HPLC autosampler must be capable of injecting from 1 to 50µL. - The HPLC autosampler must have at least six positions for plate/vials and must be able to inject from 96 shallow well plates, 96 deep well plates and vials. It must be capable of using these in combination without changing hardware configuration. - The column oven must have an operating temperature range of 5 to 85°C. - The column oven and must be able to accommodate six analytical columns of 25cm length. - The column oven must be able to accommodate and drive 2, 7-port 6-position valves to allow switching between columns and therefore multiplexing of analytical methods. - The system must be able to drive 3 2-position 6-port valves independently to allow sequential running of different methods.
What changed
From the official release history
  1. Official notice release published
    22 Jul 2026, 06:47 BST
  2. Status changed to complete
    22 Jul 2026, 06:31 BST
  3. Official notice release published
    22 Jul 2026, 06:31 BST
  4. Buyer information updated
    22 Jul 2026, 06:31 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    22 Jul 2026, 06:47 BST
  2. Award pending
    21 Jul 2026, 00:00 BST · £487,200
Commercial outcome and competition
Awards
AB Sciex UK Limited
£487,200 · 21 Jul 2026, 00:00 BST · pending
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

Contracting authority GB-NHS-RGT
View buyer profile
  • CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
    buyer

    GB-NHS: RGT · GB-PPON: PPCP-8863-HDGN
    Hills Rd, Cambridge, UKH12, CB2 0QQ, GB
  • AB Sciex UK Limited
    supplier

    GB-COH: 07007374
    Unit 4 Blythe Valley Innovation Centre, Central Boulevard, Blythe Valley Business Park, Solihull,, UKG32, B90 8AJ, GB
Award and contract changes
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published